In both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), activated PI3K upregulated ABCG2 expression and elevated percentage of cancer stem-like cells [41]. This evidence concerns the gene ABCG2 and acute lymphoblastic leukemia.